ISO 9001:2015 Certified WHO-GMP PCD Pharma Franchise Company in India300+ Products Monopoly Rights Pan India DistributionCall us: +91-86533 91199

Product List

Home / ARPOD-CV DRY SYP

EXOFEX-D

Product Packing: 100 ML

Product Composition: Dextromethorphan + Chlorpheneramine maleate + Phenylephrine HCL

Product Price: MRP : 107

EXOFEX-D

Dextromethorphan 10 mg + Chlorpheniramine Maleate 2 mg + Phenylephrine HCl 5 mg | SYP 100 ML

EXOFEX-D is an oral cough-and-cold syrup containing Dextromethorphan, Chlorpheniramine Maleate and Phenylephrine HCl. The combination provides antitussive, antihistamine and decongestant actions for short-term symptomatic relief in selected patients where this combination is approved and age-appropriate.

Dextromethorphan suppresses the cough reflex centrally, Chlorpheniramine is a first-generation H1 antihistamine that helps reduce allergy-related symptoms, and Phenylephrine is an alpha-adrenergic decongestant that reduces nasal mucosal congestion. The supplied strengths are preserved exactly, but because no per-volume basis was supplied, the exact concentration per ml or measured dose must be verified from the approved product label.

Composition

Each labelled dose contains:

· Dextromethorphan - 10 mg | Chlorpheniramine Maleate - 2 mg

· Phenylephrine HCl - 5 mg

· Syrup base / excipients - q.s. The supplied brief gives ingredient strengths but does not state the measured volume to which they apply; exact concentration per ml/measured dose must be verified from the approved product label.

Dosage form: Oral Syrup

Pack size: 100 ml

Uses of EXOFEX-D

EXOFEX-D may be used for short-term symptomatic relief of selected cough-and-cold symptoms where the combination is approved, clinically appropriate and age-appropriate.

· Dextromethorphan helps suppress troublesome dry or non-productive cough

· Chlorpheniramine helps reduce allergy-related symptoms such as sneezing and runny nose

· Phenylephrine provides nasal decongestant action by constricting swollen nasal mucosal blood vessels

· The combination may provide multi-symptom relief in selected patients when used according to the approved label

Persistent cough, breathing difficulty, wheezing, chest pain, high fever, coughing blood, bluish discoloration or worsening symptoms require appropriate medical evaluation.

How EXOFEX-D Works

EXOFEX-D combines three cough-and-cold active ingredients with complementary actions:

Dextromethorphan: A centrally acting antitussive that reduces the cough reflex. It can interact seriously with MAO inhibitors and other serotonergic medicines.

Chlorpheniramine Maleate: A first-generation H1 antihistamine that reduces histamine-mediated symptoms but can cause drowsiness, dry mouth, blurred vision and other anticholinergic effects.

Phenylephrine HCl: An alpha-adrenergic sympathomimetic decongestant that constricts nasal mucosal blood vessels and may increase blood pressure or cause palpitations in susceptible patients.

The overall response and safety depend on the exact dose, age, underlying condition, concurrent medicines and individual clinical status.

This syrup provides symptomatic relief only and does not treat the underlying cause of every cough or cold. Severe or persistent symptoms require clinical assessment.

Dosage and Direction for Use

Use EXOFEX-D strictly according to the approved product label or healthcare professional's advice. The supplied brief lists Dextromethorphan 10 mg, Chlorpheniramine Maleate 2 mg and Phenylephrine HCl 5 mg but does not state the volume containing these strengths, so no per-ml or per-5-ml dose has been inferred.

Measure the recommended quantity accurately with a calibrated measuring cup, spoon or oral syringe as appropriate.

Do not exceed the recommended dose or combine with other cough, cold, allergy or decongestant products containing the same or similar active ingredients.

Pediatric cough-and-cold medicines require age-specific caution. Use in children only when permitted by the current approved label and specifically advised by an appropriate healthcare professional.

Possible Side Effects

Possible adverse effects may include:

· Drowsiness, dizziness, impaired coordination, dry mouth, blurred vision or constipation from Chlorpheniramine

· Nausea, stomach discomfort, nervousness or dizziness

· Phenylephrine may cause palpitations, increased blood pressure, headache, restlessness or difficulty sleeping

· Excess Dextromethorphan or interactions with serotonergic medicines can cause serious neurologic effects, including serotonin syndrome

· Seek urgent medical attention for severe breathing difficulty, marked confusion or agitation, high fever with rigidity/tremor, severe palpitations, fainting, significant allergic reaction or suspected overdose.

Any persistent or troublesome adverse effect should be discussed with a healthcare professional.

Precautions and Contraindications

· Review the complete approved label before use, particularly in patients with hypertension, cardiovascular disease, hyperthyroidism, diabetes, glaucoma, urinary retention/prostatic problems or significant respiratory disease.

· Avoid use in patients with known hypersensitivity to Dextromethorphan, Chlorpheniramine, Phenylephrine or any formulation excipient.

· Do not use Dextromethorphan with monoamine oxidase inhibitors (MAOIs) or within the label-specified washout period because serious reactions, including serotonin syndrome, can occur.

· Use caution with SSRIs, SNRIs, tricyclic antidepressants and other serotonergic medicines because Dextromethorphan can increase serotonin-syndrome risk.

· Chlorpheniramine can cause sedation and anticholinergic effects. Alcohol, sedatives, opioids and other CNS depressants may increase impairment.

· Phenylephrine requires caution in hypertension, cardiovascular disease, hyperthyroidism and with other sympathomimetic/decongestant medicines. Pregnancy and breastfeeding require professional review.

· Check sweeteners, flavours, preservatives and potential allergens on the final approved label.

· Keep out of reach of children and store according to the approved pack instructions.

· Drug Interaction Considerations

· Important interactions include MAOIs and serotonergic medicines with Dextromethorphan; alcohol, sedatives and other CNS depressants with Chlorpheniramine; and other sympathomimetics or medicines affecting blood pressure/heart rate with Phenylephrine. Review the complete medication list before use.

· Provide the healthcare professional with a complete list of prescription medicines, antidepressants, OTC cough/cold products, antihistamines, decongestants, herbal products and supplements before use.

Business Growth Opportunity with EXOFEX-D

EXOFEX-D offers pharmaceutical distributors and healthcare entrepreneurs an opportunity to add a Dextromethorphan + Chlorpheniramine Maleate + Phenylephrine HCl oral syrup in a convenient 100 ml pack to their cough-and-cold portfolio.

Cough-and-cold combinations are an established therapeutic segment. Promotion must remain consistent with the final approved composition, age restrictions, prescription/regulatory status, permitted claims, ethical pharmaceutical practice and applicable regulations.

Key Business Advantages

· Triple-action cough-and-cold formulation

· Dextromethorphan + Chlorpheniramine Maleate + Phenylephrine HCl

· Antitussive + antihistamine + decongestant product concept

· Convenient 100 ml oral syrup pack

· Suitable addition to cough-and-cold portfolios subject to approved formulation, age range and indications

· Opportunity for ethical promotion through appropriate healthcare channels

PCD Pharma Franchise Opportunity for EXOFEX-D

Ethics Medinova Private Limited offers PCD Pharma Franchise opportunities for EXOFEX-D in selected territories across India, subject to availability, applicable regulations and mutually agreed business terms.

Franchise partners may benefit from the company's product portfolio, promotional support, supply coordination and business assistance.

Franchise Support May Include

· Monopoly-based territory opportunities, subject to availability

· Promotional materials and visual aids consistent with approved claims

· Product information and marketing support

· Reliable supply coordination

· Access to a growing pharmaceutical product portfolio

· Professional partner assistance

Partner with Ethics Medinova to explore PCD Pharma Franchise opportunities for EXOFEX-D and other quality-focused healthcare products.

Third-Party Manufacturing Support for Dextromethorphan + Chlorpheniramine Maleate + Phenylephrine HCl Syrup

Ethics Medinova also supports eligible businesses exploring third-party manufacturing of formulations similar to EXOFEX-D under their own brand, subject to applicable drug licensing, age-related, regulatory and manufacturing requirements.

Our third-party manufacturing support may include:

· Customized approved strengths, flavour and pack requirements, subject to regulatory feasibility

· Private-label manufacturing opportunities

· Customized packaging and branding support

· Product label and pack configuration assistance

· Manufacturing coordination through suitable licensed facilities

· Support for documentation and applicable regulatory requirements

This service may be suitable for eligible pharmaceutical companies seeking to expand an appropriately licensed cough-and-cold oral-syrup portfolio.

Frequently Asked Questions About EXOFEX-D

1. What is EXOFEX-D?

EXOFEX-D is a 100 ml oral syrup containing Dextromethorphan 10 mg, Chlorpheniramine Maleate 2 mg and Phenylephrine HCl 5 mg according to the supplied product brief.

2. What does Dextromethorphan do?

Dextromethorphan is an antitussive that suppresses the cough reflex and is generally used for selected dry or non-productive cough symptoms where appropriate.

3. What is the role of Chlorpheniramine?

Chlorpheniramine is a first-generation antihistamine that helps reduce allergy-related symptoms but may cause drowsiness and anticholinergic effects.

4. What does Phenylephrine do?

Phenylephrine is a decongestant that constricts swollen nasal mucosal blood vessels. It may raise blood pressure or cause palpitations in susceptible patients.

5. Can EXOFEX-D be combined with other cough-and-cold medicines?

Do not combine it with other products containing Dextromethorphan, antihistamines, Phenylephrine or similar decongestants unless specifically advised, because duplicate ingredients can increase adverse effects.

6. How should EXOFEX-D be taken?

Follow the approved label or healthcare professional's directions. The supplied strengths have no stated per-volume basis, so the exact measured dose must be verified from the approved label.

7. Is a PCD Pharma Franchise available for EXOFEX-D?

Yes. Ethics Medinova offers PCD Pharma Franchise opportunities for selected products and territories, subject to availability, applicable regulations and mutually agreed terms.

8. Can this formulation be manufactured under my own brand?

Eligible businesses interested in a similar Dextromethorphan + Chlorpheniramine Maleate + Phenylephrine HCl syrup may explore third-party manufacturing and private-label support with Ethics Medinova, subject to applicable drug licensing and regulatory requirements.

Disclaimer

EXOFEX-D product information in this document is for general professional and business information. The supplied product brief states Dextromethorphan 10 mg + Chlorpheneramine maleate 2 mg + Phenylephrine HCL 5 mg, SYP 100 ML; the ingredient name has been standardized here as Chlorpheniramine Maleate and HCl capitalization standardized. The brief does not state the measured volume to which these strengths apply, so no per-ml or per-5-ml concentration has been inferred. Exact composition, concentration per measured dose, approved age range, prescription/regulatory status, indications, dosage, contraindications, warnings, interactions, excipients and storage requirements must be verified against the current approved product label before manufacture, promotion, recommending, dispensing or use. Dextromethorphan has important MAOI/serotonergic interaction risks, Chlorpheniramine may cause sedation, and Phenylephrine requires cardiovascular caution. Pediatric cough-and-cold use must follow current age-specific label requirements. This document is not a substitute for professional medical advice.

Dosage Form

Therapy Wise

EXOFEX-D

EXOFEX-D

Dextromethorphan 10 mg + Chlorpheniramine Maleate 2 mg + Phenylephrine HCl 5 mg | SYP 100 ML

Composition

Pack size: 100 ml

Persistent cough, breathing difficulty, wheezing, chest pain, high fever, coughing blood, bluish discoloration or worsening symptoms require appropriate medical evaluation.

Phenylephrine HCl: An alpha-adrenergic sympathomimetic decongestant that constricts nasal mucosal blood vessels and may increase blood pressure or cause palpitations in susceptible patients.

Do not exceed the recommended dose or combine with other cough, cold, allergy or decongestant products containing the same or similar active ingredients.

· Seek urgent medical attention for severe breathing difficulty, marked confusion or agitation, high fever with rigidity/tremor, severe palpitations, fainting, significant allergic reaction or suspected overdose.

· Keep out of reach of children and store according to the approved pack instructions.

· Provide the healthcare professional with a complete list of prescription medicines, antidepressants, OTC cough/cold products, antihistamines, decongestants, herbal products and supplements before use.

Cough-and-cold combinations are an established therapeutic segment. Promotion must remain consistent with the final approved composition, age restrictions, prescription/regulatory status, permitted claims, ethical pharmaceutical practice and applicable regulations.

· Opportunity for ethical promotion through appropriate healthcare channels

Franchise partners may benefit from the company's product portfolio, promotional support, supply coordination and business assistance.

Partner with Ethics Medinova to explore PCD Pharma Franchise opportunities for EXOFEX-D and other quality-focused healthcare products.

This service may be suitable for eligible pharmaceutical companies seeking to expand an appropriately licensed cough-and-cold oral-syrup portfolio.

Frequently Asked Questions About EXOFEX-D

EXOFEX-D is a 100 ml oral syrup containing Dextromethorphan 10 mg, Chlorpheniramine Maleate 2 mg and Phenylephrine HCl 5 mg according to the supplied product brief.

Dextromethorphan is an antitussive that suppresses the cough reflex and is generally used for selected dry or non-productive cough symptoms where appropriate.

Chlorpheniramine is a first-generation antihistamine that helps reduce allergy-related symptoms but may cause drowsiness and anticholinergic effects.

Phenylephrine is a decongestant that constricts swollen nasal mucosal blood vessels. It may raise blood pressure or cause palpitations in susceptible patients.

Do not combine it with other products containing Dextromethorphan, antihistamines, Phenylephrine or similar decongestants unless specifically advised, because duplicate ingredients can increase adverse effects.

Follow the approved label or healthcare professional's directions. The supplied strengths have no stated per-volume basis, so the exact measured dose must be verified from the approved label.

Yes. Ethics Medinova offers PCD Pharma Franchise opportunities for selected products and territories, subject to availability, applicable regulations and mutually agreed terms.

Eligible businesses interested in a similar Dextromethorphan + Chlorpheniramine Maleate + Phenylephrine HCl syrup may explore third-party manufacturing and private-label support with Ethics Medinova, subject to applicable drug licensing and regulatory requirements.

Dosage Form

Therapy Wise

EXOFEX-D

EXOFEX-D

Dextromethorphan 10 mg + Chlorpheniramine Maleate 2 mg + Phenylephrine HCl 5 mg | SYP 100 ML

Composition

Pack size: 100 ml

Persistent cough, breathing difficulty, wheezing, chest pain, high fever, coughing blood, bluish discoloration or worsening symptoms require appropriate medical evaluation.

Phenylephrine HCl: An alpha-adrenergic sympathomimetic decongestant that constricts nasal mucosal blood vessels and may increase blood pressure or cause palpitations in susceptible patients.

Do not exceed the recommended dose or combine with other cough, cold, allergy or decongestant products containing the same or similar active ingredients.

· Seek urgent medical attention for severe breathing difficulty, marked confusion or agitation, high fever with rigidity/tremor, severe palpitations, fainting, significant allergic reaction or suspected overdose.

· Keep out of reach of children and store according to the approved pack instructions.

· Provide the healthcare professional with a complete list of prescription medicines, antidepressants, OTC cough/cold products, antihistamines, decongestants, herbal products and supplements before use.

Cough-and-cold combinations are an established therapeutic segment. Promotion must remain consistent with the final approved composition, age restrictions, prescription/regulatory status, permitted claims, ethical pharmaceutical practice and applicable regulations.

· Opportunity for ethical promotion through appropriate healthcare channels

Franchise partners may benefit from the company's product portfolio, promotional support, supply coordination and business assistance.

Partner with Ethics Medinova to explore PCD Pharma Franchise opportunities for EXOFEX-D and other quality-focused healthcare products.

This service may be suitable for eligible pharmaceutical companies seeking to expand an appropriately licensed cough-and-cold oral-syrup portfolio.

Frequently Asked Questions About EXOFEX-D

EXOFEX-D is a 100 ml oral syrup containing Dextromethorphan 10 mg, Chlorpheniramine Maleate 2 mg and Phenylephrine HCl 5 mg according to the supplied product brief.

Dextromethorphan is an antitussive that suppresses the cough reflex and is generally used for selected dry or non-productive cough symptoms where appropriate.

Chlorpheniramine is a first-generation antihistamine that helps reduce allergy-related symptoms but may cause drowsiness and anticholinergic effects.

Phenylephrine is a decongestant that constricts swollen nasal mucosal blood vessels. It may raise blood pressure or cause palpitations in susceptible patients.

Do not combine it with other products containing Dextromethorphan, antihistamines, Phenylephrine or similar decongestants unless specifically advised, because duplicate ingredients can increase adverse effects.

Follow the approved label or healthcare professional's directions. The supplied strengths have no stated per-volume basis, so the exact measured dose must be verified from the approved label.

Yes. Ethics Medinova offers PCD Pharma Franchise opportunities for selected products and territories, subject to availability, applicable regulations and mutually agreed terms.

Eligible businesses interested in a similar Dextromethorphan + Chlorpheniramine Maleate + Phenylephrine HCl syrup may explore third-party manufacturing and private-label support with Ethics Medinova, subject to applicable drug licensing and regulatory requirements.

We value your privacy

Get the Product Details